Ensnared in the Web

On April 30, 2003, my office phone rang.

Written byStephen Wolniak
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On April 30, 2003, my office phone rang. The caller, who wouldn't identify himself, wanted to discuss messages I had allegedly posted about the Eli Lilly Company on a Yahoo! Finance message board. Prior to the call, I knew nothing of the board's existence, but I soon learned that for more than a month, I was the subject of repeated attacks on the forum because I had been misidentified as an antagonist there who went by the screen name Mitosis03.

Users of the board thought I was Mitosis03, because in 1997 I had created a mitosis Web site as a cell biology course supplement.1 By 2002, the site was averaging more than 50 page views per day from students around the world, with each user spending an average of 2.5 minutes on the home page. When a board user searched the Web for "mitosis," they found my site and assumed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies